摘要
目的:探讨Bcl-2相关抗凋亡基因3(Bcl-2-associated athanogene 2,BAG3)在蛋白酶体抑制剂诱导卵巢癌SKOV3细胞凋亡中的作用。方法:选取人卵巢癌细胞系SKOV3,分别设培养液处理空白对照组、蛋白酶体抑制剂MG132处理组和MG132+Z-VAD联合处理组,按不同时段处理细胞。实时定量RT-PCR法检测各组细胞BAG3 mRNA表达及MG132诱导其表达时效性,Western blot蛋白印迹法检测各组细胞BAG3蛋白表达,流式细胞仪(FCM)检测细胞凋亡。结果:与空白对照组相比,在MG132诱导作用下,SKOV3细胞中BAG3 mRNA表达增加(P<0.01),并随作用时间呈现时效性。发现40kDa BAG3分裂产物,其细胞凋亡率亦随之增加。结论:蛋白酶体抑制剂可诱导上调卵巢癌细胞中BAG3基因表达,BAG3蛋白裂解导致细胞凋亡增加,这一效应可能依赖caspase介导完成。
Objective:To investigate the role of BAG3 in proteasome inhibitor mediated apoptosis in ovarian cancer cells. Methods: SKOV3 cell was cultured and treated with vehicle, MG132, pancaspase inhibitor Z - VAD or combination of Z -VAD and MG132. BAG3 mRNA and protein levels were analyzed by using qPCR and Western blot,respectively. Flow cytometry (FCM) was used to determine the apoptotic rate of cells. Results: Compared with the blank group,BAG3 mRNA expression in the ceils was increased by MG132 in a time -dependence manner (P 〈0. 01 ) ,and simultaneously,cleavage product of BAG3 could be induced by MG132, accompanied with increasing apoptosis rate. Conclusion:Proteasome inhibitor MG132 induces the expression of BAG3 in SKOV3 cells. In proteasome inhibitor treated ceils, BAG3 is cleaved in a caspase- dependent manner.
出处
《现代肿瘤医学》
CAS
2013年第5期991-994,共4页
Journal of Modern Oncology